$396.73
▼ -0.1% Today
as of Sep 4, 16:55 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 0
● 24
▼ 1
2 Reasons to Like UNH and 1 to Stay Skeptical
UnitedHealth Falls as 30% of Approval Barriers Vanish
UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?
Overview
52-week range
$256
$462
68% of range
Avg surprise (last 1)
-15.7%
Avg reaction (last 0)
—
Latest IV / EM
29%
EM ±1.2% · $400 · Sep 4
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $6.04 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $6.90 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $2.59 | — | — | — | — | financials |
| Tue Jul 29, 2025 | Jun/2025 | $4.08 | $4.84 | -15.7% | — | — | earnings |
| Mon Mar 31, 2025 | Mar 2025 | $6.85 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $6.51 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $4.54 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.53 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $6.24 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $5.82 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $5.95 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $112.03B | $111.72B | — | $113.16B | $111.62B | $109.58B | $100.82B | $98.86B |
| Cost of revenue | $13.38B | $12.82B | — | $12.57B | $13.02B | $12.39B | $11.83B | $11.34B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $7.99B | $8.99B | — | $4.32B | $5.15B | $9.12B | $8.71B | $7.88B |
| Net income | $5.48B | $6.28B | — | $2.35B | $3.41B | $6.29B | $6.05B | $4.22B |
| EPS (diluted) | $6.04 | $6.90 | — | $2.59 | $3.74 | $6.85 | $6.51 | $4.54 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $28.59B | $28.00B | $24.36B | $27.21B | $28.60B | $30.72B | $32.40B | $26.29B |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $86.86B | $91.13B | $90.58B | $95.07B | $93.70B | $96.28B | $92.26B | $92.04B |
| Total assets | $309.73B | $312.64B | $309.58B | $315.27B | $308.57B | $309.79B | $299.31B | $286.06B |
| Long-term debt | $69.50B | $71.44B | $72.32B | $72.40B | $73.50B | $71.28B | $74.10B | $63.73B |
| Total liabilities | $203.78B | $207.32B | $207.88B | $209.46B | $203.79B | $204.62B | $194.85B | $186.82B |
| Total equity | $104.51B | $103.89B | $100.09B | $101.57B | $100.47B | $100.81B | $99.88B | $94.68B |